Published in Dermatology on January 01, 2007
Giant hemosiderotic dermatofibroma: a case report and review of the literature. Case Rep Dermatol (2011) 1.01
Hemosiderotic dermatofibroma: clinical and dermoscopic presentation mimicking melanoma. J Dermatol Case Rep (2015) 0.75
Multiple Eruptive Dermatofibromas Masquerading as Cutaneous Lymphoma. Indian J Dermatol (2016) 0.75
Concordance between telepathologic diagnosis and conventional histopathologic diagnosis: a multiobserver store-and-forward study on 20 skin specimens. Arch Dermatol (2002) 2.07
Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions. J Clin Oncol (1996) 1.67
Granular cell ameloblastoma: a case report with histochemical findings. Eur J Cancer B Oral Oncol (1996) 1.49
Silencing the MET oncogene leads to regression of experimental tumors and metastases. Oncogene (2007) 1.42
Morphometric analysis of AgNORs in uveal malignant melanoma. Anal Quant Cytol Histol (1998) 1.39
A primary, lateral-cervical medullary thyroid carcinoma: a case report. J Clin Endocrinol Metab (1996) 1.38
Transcatheter closure of persistent ductus arteriosus with the Amplatzer duct occluder in very young symptomatic children. Heart (2004) 1.31
Clinically equivocal melanocytic skin lesions with features of regression: a dermoscopic-pathological study. Br J Dermatol (2004) 1.27
Field cancerization in oral lichen planus. Eur J Surg Oncol (2006) 1.19
Diagnostic and prognostic implications of the World Health Organization classification of neuroendocrine tumors. J Endocrinol Invest (2008) 1.14
Accelerated bone mass senescence after hematopoietic stem cell transplantation. Transl Med UniSa (2013) 1.13
Survivin, a potential early predictor of tumor progression in the oral mucosa. J Dent Res (2003) 1.13
Th17/Tc17 infiltration and associated cytokine gene expression in elicitation phase of allergic contact dermatitis. Br J Dermatol (2009) 1.11
Expression of cell cycle and apoptosis-related proteins in sporadic odontogenic keratocysts and odontogenic keratocysts associated with the nevoid basal cell carcinoma syndrome. J Dent Res (1999) 1.08
An anomalous positron abundance in cosmic rays with energies 1.5-100 GeV. Nature (2009) 1.07
Odontogenic myxoma: report of a case with peculiar features. J Oral Maxillofac Surg (1991) 1.06
Tricholemmal carcinoma: a study of seven cases. J Cutan Pathol (1992) 1.06
Survivin expression in oral squamous cell carcinoma. Br J Cancer (2003) 1.06
Huge primary retroperitoneal mucinous cystadenoma of borderline malignancy mimicking an ovarian mass: case report and review. Anticancer Res (2008) 1.06
Diagnostic accuracy of the serum profile of gastric mucosa in relation to histological and morphometric diagnosis of atrophy. Aliment Pharmacol Ther (2005) 1.05
Is serum troponin T a useful marker of myocardial damage in newborn infants with perinatal asphyxia? Acta Paediatr (2007) 1.05
Cardiac adverse effects of early dexamethasone treatment in preterm infants: a randomized clinical trial. J Clin Pharmacol (2001) 1.05
Primary monotypic epithelioid angiomyolipoma of bone. Histopathology (2002) 1.04
Expression of teratocarcinoma-derived growth factor-1 (TDGF-1) in testis germ cell tumors and its effects on growth and differentiation of embryonal carcinoma cell line NTERA2/D1. Oncogene (1997) 1.01
A case of mesonephric adenocarcinoma of the vagina with a 1-year follow-up. Int J Gynecol Cancer (2007) 1.00
Primary Ewing's sarcoma of the maxilla, a rare and curable localization: report of two new cases, successfully treated by radiotherapy and systemic chemotherapy. Cancer Lett (1996) 0.98
Self-assembly nanoparticles for the delivery of bisphosphonates into tumors. Int J Pharm (2010) 0.97
Facial granulomatous diseases: a study of four cases tested for the presence of Mycobacterium tuberculosis DNA using nested polymerase chain reaction. Am J Dermatopathol (2001) 0.96
Tumor infiltrating lymphocytes in uveal melanoma: a link with clinical behavior? Int J Immunopathol Pharmacol (2006) 0.95
Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma. Exp Mol Pathol (2001) 0.93
Dermatoscopic pitfalls in differentiating pigmented Spitz naevi from cutaneous melanomas. Br J Dermatol (1999) 0.92
New measurement of the antiproton-to-proton flux ratio up to 100 GeV in the cosmic radiation. Phys Rev Lett (2009) 0.92
Scatter factor receptor (c-Met) as possible prognostic factor in patients with oral squamous cell carcinoma. Anticancer Res (2004) 0.91
OPN/CD44v6 overexpression in laryngeal dysplasia and correlation with clinical outcome. Br J Cancer (2007) 0.91
Nanotech revolution for the anti-cancer drug delivery through blood-brain barrier. Curr Cancer Drug Targets (2012) 0.91
Expression of biomarkers modulating prostate cancer progression: implications in the treatment of the disease. Prostate Cancer Prostatic Dis (2005) 0.91
PLGA microspheres encapsulating siRNA anti-TNFalpha: efficient RNAi-mediated treatment of arthritic joints. Eur J Pharm Biopharm (2012) 0.91
Angiomatoid malignant fibrous histiocytoma: cytologic, immunohistochemical, ultrastructural, and flow cytometric study of 20 cases. Mod Pathol (1990) 0.90
Variations of proline-rich kinase Pyk2 expression correlate with prostate cancer progression. Lab Invest (2001) 0.90
Educational and motivational support service: a pilot study for mobile-phone-based interventions in patients with psoriasis. Br J Dermatol (2012) 0.90
Fine-needle aspiration biopsies of breast masses. A critical analysis of 1956 cases in 8 years (1976-1984). Cancer (1988) 0.89
Prolactin secretion after beer. Lancet (1981) 0.89
Telediagnosis and face-to-face diagnosis reliability for melanocytic and non-melanocytic 'pink' lesions. J Eur Acad Dermatol Venereol (2008) 0.89
Chromatin assembly factor-1 (CAF-1)-mediated regulation of cell proliferation and DNA repair: a link with the biological behaviour of squamous cell carcinoma of the tongue? Histopathology (2007) 0.89
Beta- and gamma-catenin expression in oral squamous cell carcinomas. Anticancer Res (2000) 0.88
Estrogen receptor beta expression in human prostate tissue. Mol Cell Endocrinol (2001) 0.88
The prognostic significance of tumor angiogenesis in nonaggressive and aggressive basal cell carcinoma of the human skin. Hum Pathol (1996) 0.87
Expression of proto-oncogene c-kit in high risk prostate cancer. Eur J Surg Oncol (2004) 0.87
Thymoma: a clinico-pathologic study based on newly developed morphologic criteria. Tumori (1988) 0.87
Loss of oestrogen receptor beta, high PCNA and p53 expression and aneuploidy as markers of worse prognosis in ovarian granulosa cell tumours. Histopathology (2003) 0.87
HSP 27 as possible prognostic factor in patients with oral squamous cell carcinoma. Histol Histopathol (2004) 0.87
Left ventricle dimensions in preterm infants during the first month of life. Eur J Pediatr (2001) 0.87
Microstructural disorders of tunica albuginea in patients affected by Peyronie's disease with or without erection dysfunction. J Urol (1993) 0.86
Sinonasal lymphoma presenting as a lethal midline granuloma: case report. J Oral Maxillofac Surg (1998) 0.86
Epithelioid hemangioendothelioma of the larynx. Tumori (2000) 0.86
Acute cholestasis: atypical onset of Kawasaki disease. Dig Liver Dis (2007) 0.86
Nicotinamide downregulates gene expression of interleukin-6, interleukin-10, monocyte chemoattractant protein-1, and tumour necrosis factor-α gene expression in HaCaT keratinocytes after ultraviolet B irradiation. Clin Exp Dermatol (2013) 0.86
Liver resection in patients with eight or more colorectal liver metastases. Br J Surg (2015) 0.86
MASC is indistinguishable from acinic cell carcinoma, papillary-cystic variant on salivary gland FNA cytomorphology: case report with histological and immunohistochemical correlates. Cytopathology (2013) 0.85
Evidence that protease activated receptor 2 expression is enhanced in human coronary atherosclerotic lesions. J Clin Pathol (2004) 0.85
Echographic examination with new generation contrast agent of choroidal malignant melanomas. Acta Ophthalmol Scand (2005) 0.85
Prevalence of HCV antibodies in autoimmune thyroid disease. Eur Rev Med Pharmacol Sci (2006) 0.85
Histopathologic interobserver agreement on the diagnosis of melanocytic skin lesions with equivocal dermoscopic features: a pilot study. Tumori (2001) 0.85
Role of tachykinins in the bronchoconstriction induced by HCl intraesophageal instillation in the rabbit. Life Sci (2003) 0.85
Tracheobronchial aspergillosis in a patient with AIDS treated with aerosolized amphotericin B combined with itraconazole. Mycoses (1997) 0.84
Potentially malignant and malignant lesions of the lip. Role of silver staining nucleolar organizer regions, proliferating cell nuclear antigen, p53, and c-myc in differentiation and prognosis. J Oral Pathol Med (1999) 0.84
Immunohistochemical expression of mdm2 and p21WAF1 in invasive cervical cancer: correlation with p53 protein and high risk HPV infection. J Clin Pathol (1998) 0.84
Synchronous primary adenocarcinoma and adenosquamous carcinoma of the esophagus. Eur Radiol (2001) 0.84
An unusual orbital lesion: hepatoma metastatic to the orbit. Ophthalmologica (1994) 0.84
Increased cardiac mast cell density and mediator release in patients with dilated cardiomyopathy. Inflamm Res (1997) 0.84
Peripheral ameloblastoma: report of a case with malignant aspect. Br J Oral Maxillofac Surg (1996) 0.84
Prognostic value of human telomerase reverse transcriptase gene expression in oral carcinogenesis. Int J Oncol (2007) 0.84
Cyclooxygenase-2 expression in oral squamous cell carcinoma. Int J Immunopathol Pharmacol (2004) 0.84
Calcitriol plus hydrochlorothiazide prevents transient post-thyroidectomy hypocalcemia. Horm Metab Res (2006) 0.84
Secondary syphilis mimicking pemphigus vulgaris. J Eur Acad Dermatol Venereol (2009) 0.83
Cutaneous metastases from gastric adenocarcinoma. Report of two cases and review of the literature. Arch Anat Cytol Pathol (1996) 0.83
Modulation of in vivo growth of thyroid tumor-derived cell lines by sense and antisense vascular endothelial growth factor gene. Oncogene (1999) 0.83
Genetic analysis of oral squamous cell carcinoma by cDNA microarrays focused apoptotic pathway. Int J Immunopathol Pharmacol (2006) 0.83
Nuclear DNA content-derived parameters correlated with heterogeneous expression of p53 and bcl-2 proteins in clear cell renal carcinomas. Cancer (2000) 0.83
Neurothekeoma of the thumb. A case report. Tumori (1988) 0.83
Thyroid cancer in suppressed contralateral lobe of patients with hot thyroid nodule. Eur J Cancer (1993) 0.82
Elastofibroma dorsi: a histochemical and immunohistochemical study. Eur J Histochem (2015) 0.82
Acinic cell carcinoma arising in a lacrimal gland. First case report. Cancer (1986) 0.82
Histopathological determinants of tumor resistance: a special look to the immunohistochemical expression of carbonic anhydrase IX in human cancers. Curr Med Chem (2014) 0.82
Smooth muscle tumors of the breast: clinicopathologic features of two cases. Tumori (1994) 0.82
The NM23 gene and its expression in oral squamous cell carcinoma. Oncol Rep (1999) 0.82
The influence of hormone replacement therapy on the pathology of breast cancer. Eur J Surg Oncol (2005) 0.82
DNA ploidy and cyclin D1 expression in basal cell carcinoma of the head and neck. Am J Clin Pathol (2001) 0.82
Danazol: in vitro effects on human hemopoiesis and in vivo activity in hypoplastic and myelodysplastic disorders. Eur J Haematol (1991) 0.82
In vivo characterisation of soft tissue tumours by 1.5-T proton MR spectroscopy. Eur Radiol (2011) 0.81
Donor lymphocyte infusion for post-transplant relapse of Hodgkin's lymphoma. Haematologica (2000) 0.81
Interaction between bcl-2 and P53 in neoplastic progression of basal cell carcinoma of the head and neck. Anticancer Res (2002) 0.81
Up-regulation of heparin binding epidermal growth factor-like growth factor and amphiregulin expression in Helicobacter pylori-infected human gastric mucosa. Dig Liver Dis (2002) 0.81